425 related articles for article (PubMed ID: 25384486)
1. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
[TBL] [Abstract][Full Text] [Related]
2. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
3. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
[TBL] [Abstract][Full Text] [Related]
4. The pneumococcal conjugate vaccine had a sustained effect on Swedish children 8 years after its introduction.
Alfvén T; Bennet R; Granath A; Dennison SH; Eriksson M
Acta Paediatr; 2024 Apr; 113(4):764-770. PubMed ID: 38217260
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
[TBL] [Abstract][Full Text] [Related]
6. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.
Poehling KA; Talbot TR; Griffin MR; Craig AS; Whitney CG; Zell E; Lexau CA; Thomas AR; Harrison LH; Reingold AL; Hadler JL; Farley MM; Anderson BJ; Schaffner W
JAMA; 2006 Apr; 295(14):1668-74. PubMed ID: 16609088
[TBL] [Abstract][Full Text] [Related]
7. Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013.
Martinelli D; Pedalino B; Cappelli MG; Caputi G; Sallustio A; Fortunato F; Tafuri S; Cozza V; Germinario C; Chironna M; Prato R;
Hum Vaccin Immunother; 2014; 10(1):33-9. PubMed ID: 24096297
[TBL] [Abstract][Full Text] [Related]
8. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
[TBL] [Abstract][Full Text] [Related]
9. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
Grijalva CG; Nuorti JP; Arbogast PG; Martin SW; Edwards KM; Griffin MR
Lancet; 2007 Apr; 369(9568):1179-86. PubMed ID: 17416262
[TBL] [Abstract][Full Text] [Related]
10. [Value of pneumococcal vaccination in infants and young children].
Adam D; Scholz H
Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
[TBL] [Abstract][Full Text] [Related]
11. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
12. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
13. Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7).
Chibuk TK; Robinson JL; Hartfield DS
Eur J Pediatr; 2010 Sep; 169(9):1123-8. PubMed ID: 20383524
[TBL] [Abstract][Full Text] [Related]
14. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
[TBL] [Abstract][Full Text] [Related]
15. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
Miller E; Andrews NJ; Waight PA; Slack MP; George RC
Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
Adam D; Fehnle K
Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
[TBL] [Abstract][Full Text] [Related]
18. [Bacteremic pneumococcal pneumonia].
Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
[TBL] [Abstract][Full Text] [Related]
19. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):1-4. PubMed ID: 19145219
[TBL] [Abstract][Full Text] [Related]
20. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Reinert RR
Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
